Controllable delivery from Gentamicin (cas 1403-66-3) loaded polycaprolactone/grafted silica nanoparticles composite mats
-
Add time:09/06/2019 Source:sciencedirect.com
Sustained and controlled drug delivery system has an important application in the field of tissue regeneration. In this study, drug loaded MCM-41 silica was used to fabricate nano-composite fibres for efficient and extended drug carrier in deep wounds dressing. Mesoporous silica nanoparticles were synthesized using the co-synthesis (Cl-SiO2@Co), and post-grafting methodologies (Cl-SiO2@Po). The Gentamicin (cas 1403-66-3) antibiotic loaded silica was incorporated in PCL solution to fabricate the PCL-based electro spun nano-composite mats through emulsion electrospinning method. The silica and electro spun nano-composite mats were characterized with Scanning Electron Microscopy (SEM), Infrared Spectroscopy (FTIR) as well as BET surface analyzer to obtain the structural parameters. The silica and fabricated electro spun mats were also evaluated for biocompatibility through MTT assay. The loading of gentamicin on Cl-SiO2@Po was 26.1 w/w % and Cl-SiO2@Co was approximately 41 w/w %. The drug loaded silica/PCL nanocomposites electro spun mats was evaluated for drug release study for 336 h. In comparison to nano fibres of silicaCl-SiO2@Po (post-grafted), the release of gentamicin from theCl-SiO2@Co (co-synthesized) fibres was very slow and almost half of the drug (54%) was released during two weeks. The obtained results suggest that the fabricated materials can be used as an extended drug delivery system in wounds dressings to prevent the microbial infection.
We also recommend Trading Suppliers and Manufacturers of Gentamicin (cas 1403-66-3). Pls Click Website Link as below: cas 1403-66-3 suppliers
Prev:Improving Gentamicin (cas 1403-66-3) B and Gentamicin (cas 1403-66-3) C1a production by engineering the glycosyltransferases that transfer primary metabolites into secondary metabolites biosynthesis
Next:Synthesis of Gentamicin (cas 1403-66-3)-grafted-chitosan with improved solubility and antibacterial activity) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperEvaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, Gentamicin (cas 1403-66-3) and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility09/10/2019
- Electrospinning of silica nanoparticles-entrapped nanofibers for sustained Gentamicin (cas 1403-66-3) release09/09/2019
- Microbicidal Gentamicin (cas 1403-66-3)-alginate hydrogels09/08/2019
- Synthesis of Gentamicin (cas 1403-66-3)-grafted-chitosan with improved solubility and antibacterial activity09/07/2019
- Improving Gentamicin (cas 1403-66-3) B and Gentamicin (cas 1403-66-3) C1a production by engineering the glycosyltransferases that transfer primary metabolites into secondary metabolites biosynthesis09/05/2019
- Original articleEffect of Withania somnifera on Gentamicin (cas 1403-66-3) induced renal lesions in rats09/04/2019
- Intratympanic mixture Gentamicin (cas 1403-66-3) and dexamethasone versus dexamethasone for unilateral Meniere's disease09/03/2019
- Overproduction of Gentamicin (cas 1403-66-3) B in industrial strain Micromonospora echinospora CCTCC M 2018898 by cloning of the missing genes genR and genS09/02/2019
- Original ArticleStandard-dose Gentamicin (cas 1403-66-3) does not increase risk of patent ductus arteriosus09/01/2019


